Rehabilitation Treatment of Anterior Cruciate Ligament Rupture
Launched by AARHUS UNIVERSITY HOSPITAL · May 26, 2020
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how effective a non-surgical rehabilitation program is for patients with an Anterior Cruciate Ligament (ACL) injury. The goal is to see if this treatment helps improve patients' knee function and overall quality of life, and to find out how many patients eventually need surgery instead. The study is currently looking for participants aged between 18 and 62 years who have chosen a rehabilitation approach for their ACL injury.
If you decide to participate, you will be asked to complete surveys about your knee function and daily activities. The trial is open to all genders, but you won’t be eligible if you have other knee ligament issues, rheumatoid arthritis, or a specific type of arthritis called Morbus Bechterews Disease. This is an important opportunity to help researchers understand better ways to treat ACL injuries without surgery, potentially benefiting many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anterior cruciate ligament injury where rehabilitation regime is selected as treatment.
- Exclusion Criteria:
- • Other knee ligament instability
- • Rheumatoid arthritis
- • Morbus Bechterews Disease
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials